FHIR IG Statistics: ValueSet/2.16.840.1.113883.3.1444.3.158
Package | us.nlm.vsac |
Resource Type | ValueSet |
Id | 2.16.840.1.113883.3.1444.3.158 |
FHIR Version | R4 |
Source | http://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113883.3.1444.3.158/expansion |
URL | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.158 |
Version | 20241126 |
Status | active |
Date | 2024-11-26T01:08:36-05:00 |
Name | BortezomibInjectable |
Title | Bortezomib Injectable |
Realm | us |
Authority | hl7 |
Purpose | (Clinical Focus: The purpose of this value set is to represent concepts of medication Bortezomib.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent a medication Bortezomib; generic; prescribable; injectable.),(Exclusion Criteria: Excludes concepts that represent non-prescribable branded drugs, components or ingredients.) |
Resources that use this resource
Resources that this resource uses
Narrative
No narrative content found in resource
Source
{
"resourceType": "ValueSet",
"id": "2.16.840.1.113883.3.1444.3.158",
"meta": {
"versionId": "19",
"lastUpdated": "2024-11-26T01:08:36.000-05:00",
"profile": [
"http://hl7.org/fhir/StructureDefinition/shareablevalueset",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
]
},
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-author",
"valueContactDetail": {
"name": "American Society of Clinical Oncology Author"
}
},
{
"url": "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
"valueDate": "2025-04-08"
},
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
"valueDate": "2024-11-26"
}
],
"url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.158",
"identifier": [
{
"system": "urn:ietf:rfc:3986",
"value": "urn:oid:2.16.840.1.113883.3.1444.3.158"
}
],
"version": "20241126",
"name": "BortezomibInjectable",
"title": "Bortezomib Injectable",
"status": "active",
"date": "2024-11-26T01:08:36-05:00",
"publisher": "American Society of Clinical Oncology Steward",
"jurisdiction": [
{
"coding": [
{
"system": "urn:iso:std:iso:3166",
"code": "US"
}
]
}
],
"purpose": "(Clinical Focus: The purpose of this value set is to represent concepts of medication Bortezomib.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent a medication Bortezomib; generic; prescribable; injectable.),(Exclusion Criteria: Excludes concepts that represent non-prescribable branded drugs, components or ingredients.)",
"compose": {
"include": [
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"concept": [
{
"code": "2601542",
"display": "bortezomib 1 MG Injection"
},
{
"code": "2601544",
"display": "bortezomib 2.5 MG Injection"
},
{
"code": "2608948",
"display": "1.4 ML bortezomib 2.5 MG/ML Injection"
},
{
"code": "2608952",
"display": "3.5 ML bortezomib 1 MG/ML Injection"
},
{
"code": "402243",
"display": "bortezomib 3.5 MG Injection"
}
]
}
]
},
"expansion": {
"identifier": "urn:uuid:61516f07-534a-4aa7-8f16-63b586d4afab",
"timestamp": "2025-05-23T21:53:31-04:00",
"total": 5,
"contains": [
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "2601542",
"display": "bortezomib 1 MG Injection"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "2601544",
"display": "bortezomib 2.5 MG Injection"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "2608948",
"display": "1.4 ML bortezomib 2.5 MG/ML Injection"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "2608952",
"display": "3.5 ML bortezomib 1 MG/ML Injection"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "402243",
"display": "bortezomib 3.5 MG Injection"
}
]
}
}